Part D Plan Preference for Higher-Cost Hepatitis C Drugs Led to Higher Medicare and Beneficiary Spending
Read the ReportWhat's New
- August 11, 2022
- Part D Plan Preference for Higher-Cost Hepatitis C Drugs Led to Higher Medicare and Beneficiary Spending OEI-BL-21-00200
- South Carolina Did Not Always Invoice Rebates to Manufacturers for Physician-Administered Drugs A-07-21-07003
- Updated: Corporate Integrity Agreements
- August 5, 2022
- Updated:
Enforcement Actions
- August 10, 2022; U.S. Attorney's Office, Southern District of Indiana
- U.S. Attorney's Office Recovers Over $5.5 Million in Civil False Claims Settlement with American Senior Communities
- August 9, 2022; U.S. Attorney's Office, Western District of Pennsylvania
- Five Individuals and Two Nursing Facilities Indicted on Charges of Conspiracy to Defraud the United States and Health Care Fraud
- August 9, 2022; U.S. Attorney's Office, Southern District of Georgia
- Georgia nurse practitioner sentenced to prison, ordered to pay more than $1.6 million in restitution in complex telemedicine fraud scheme